Glenmark's FabiFlu approved for coronavirus treatment in India, costs Rs 103 per tablet - India Today
Index - Tech-Tudomány - Mit tud a koronavírus-gyógyszer, amit Kínából kaptunk?
Glenmark launches Favipiravir for treatment of mild to moderate COVID-19 patients
Favipiravir 200 mg Manufacturer, Supplier, Exporter
A háziorvos is felírhatja ezentúl a koronavírus-betegeknek a favipiravir hatóanyagú gyógyszert
Drug firms race to launch Favipiravir as antiviral gains traction in mild-moderate COVID-19 care
Govt. Stockpiles More Medicine for Treating
Antiviral Drugs - FAVISERN-400 (Favipiravir Tablets 400 Mg) Manufacturer from Ludhiana
DCGI pulls up Glenmark for false claims, overpricing of covid-19 drug FabiFlu | Mint
Health Ministry Will Administer Favipiravir to All COVID-19 Patients
Favipira (Favipiravir) - Beacon Pharmaceuticals PLC
The Japanese Government Delivered 12200 Avigan Tablets For Treatment Of Covid 19 In Indonesia | Portal Kementerian Luar Negeri Republik Indonesia
Már a háziorvos is felírhatja a koronavírus-betegeknek a favipiravir hatóanyagú gyógyszert - Portfolio.hu
DCGI: Bal Pharma launches antiviral drug Favipiravir at Rs 85/tablet, ET HealthWorld
Hetero launches generic favipiravir to treat Covid-19 in India - Pharmaceutical Technology
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care - The Lancet Respiratory Medicine
Cipla to launch favipiravir under Ciplenza in August at 68 rupees per pill | Mint
Favipiravir 400Mg Tablet at Best Price in Delhi, Delhi | Corporate Opportunity Services
Favipiravir shows good clinical efficacy in treating COVID-19: official - Xinhua | English.news.cn
Avigan influenza antiviral to enter phase III trials in COVID-19 patients
Valóban hatásos a koronavírus ellen a favipiravir? Vitába szállt a gyógyszerhatósággal a Tudományos Akadémia
Kiakadt az Akadémia a gyógyszervita elfojtásán
